For the year ending 2025-12-31, AFCG had -$65,004,953 decrease in cash & cash equivalents over the period.
| Cash Flow | 2025-12-31 |
|---|---|
| Net (loss) income from continuing operations | -20,673,426 |
| Provision for current expected credit losses | 22,590,706 |
| Realized losses on investments, net | 0 |
| Gain on extinguishment of debt | 359,305 |
| Change in unrealized losses on loans at fair value, net | -7,933,276 |
| Accretion of deferred loan original issue discount and other discounts | 3,450,808 |
| Amortization of deferred financing costs-Line Of Credit | 252,759 |
| Amortization of deferred financing costs-Senior Notes | 623,647 |
| Stock-based compensation | 6,840,805 |
| Payment-in-kind interest | 464,809 |
| Interest receivable | -1,083,515 |
| Prepaid expenses and other assets | 1,236,349 |
| Accrued interest | -131,431 |
| Accrued management and incentive fees, net | -1,216,065 |
| Accrued direct administrative expenses | -822,666 |
| Accounts payable and other liabilities | 265,503 |
| Net cash provided by operating activities of continuing operations | 11,235,352 |
| Net cash provided by operating activities of discontinued operations | 0 |
| Net cash provided by operating activities | 11,235,352 |
| Issuance of and fundings on loans | 45,460,583 |
| Proceeds from sales of loans | 0 |
| Principal repayment of loans | 80,365,080 |
| Net cash provided by investing activities of continuing operations | 34,904,497 |
| Net cash used in investing activities of discontinued operations | 0 |
| Net cash provided by (used in) investing activities | 34,904,497 |
| Proceeds from sale of common stock | 0 |
| Payment of offering costs - equity offering | 0 |
| Payment of financing costs | 280,406 |
| Redemption of preferred shares | 0 |
| Cash distribution in connection with the spin-off of suns | 0 |
| Borrowings on revolving credit facilities | 91,600,000 |
| Repayments on revolving credit facilities | 170,600,000 |
| Dividends paid to common and preferred shareholders | 19,345,396 |
| Repayment of senior notes | 12,519,000 |
| Net cash used in financing activities of continuing operations | -111,144,802 |
| Net cash provided by (used in) financing activities of discontinued operations | 0 |
| Net cash used in financing activities | -111,144,802 |
| Net (decrease) increase in cash and cash equivalents | -65,004,953 |
| Cash and cash equivalents, beginning of period | 103,610,460 |
| Cash and cash equivalents, end of period | 38,605,507 |
Advanced Flower Capital Inc. (AFCG)
Advanced Flower Capital Inc. (AFCG)